NanoEcho ABOMXSTO: NANECH

NANECH: Clinical milestones reached, losses narrowed, and first revenues expected soon

· Issued by NanoEcho AB

Key clinical milestones achieved, including first clinical study completion and initial clinical image publication. Net loss narrowed year-over-year, with cash position improved and financial runway extended to December 2025. Market outlook remains strong, with first revenues expected soon.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

NanoEcho AB on 6ix

Story so far

Earlier from NanoEcho

Later from NanoEcho

All NanoEcho news releases